Related Experiment Video
Updated: Jun 26, 2025

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses
Published on: February 25, 2011
Structural mechanism of angiogenin activation by the ribosome
Anna B Loveland1, Cha San Koh2, Robin Ganesan3
1RNA Therapeutics Institute, UMass Chan Medical School, Worcester, MA, USA. anna.loveland@umassmed.edu.
Abstract:
Angiogenin, an RNase-A-family protein, promotes angiogenesis and has been implicated in cancer, neurodegenerative diseases and epigenetic inheritance1-10. After activation during cellular stress, angiogenin cleaves tRNAs at the anticodon loop, resulting in translation repression11-15. However, the catalytic activity of isolated angiogenin is very low, and the mechanisms of the enzyme activation and tRNA specificity have remained a puzzle3,16-23. Here we identify these mechanisms using biochemical assays and cryogenic electron microscopy (cryo-EM). Our study reveals that the cytosolic ribosome is the activator of angiogenin. A cryo-EM structure features angiogenin bound in the A site of the 80S ribosome. The C-terminal tail of angiogenin is rearranged by interactions with the ribosome to activate the RNase catalytic centre, making the enzyme several orders of magnitude more efficient in tRNA cleavage. Additional 80S-angiogenin structures capture how tRNA substrate is directed by the ribosome into angiogenin's active site, demonstrating that the ribosome acts as the specificity factor. Our findings therefore suggest that angiogenin is activated by ribosomes with a vacant A site, the abundance of which increases during cellular stress24-27. These results may facilitate the development of therapeutics to treat cancer and neurodegenerative diseases.
Insights
The cytosolic ribosome activates angiogenin, an enzyme implicated in diseases like cancer. Ribosomes guide tRNA to angiogenin, enhancing its catalytic activity and specificity for potential therapeutics.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Angiogenin, an RNase-A protein, is involved in angiogenesis, cancer, and neurodegenerative diseases.
- Activated angiogenin cleaves tRNAs, causing translation repression, but its activation and specificity mechanisms were unclear.
Purpose of the Study:
- To elucidate the activation mechanisms and tRNA specificity of angiogenin.
- To understand how angiogenin's catalytic activity is regulated.
Main Methods:
- Biochemical assays
- Cryogenic electron microscopy (cryo-EM) to determine structures of angiogenin bound to the 80S ribosome.
Main Results:
- The cytosolic ribosome acts as the activator of angiogenin.
- Cryo-EM structures show angiogenin bound to the 80S ribosome A site, with its C-terminal tail rearranged for RNase activation.
- The ribosome directs tRNA substrate into angiogenin's active site, conferring specificity.
Conclusions:
- Ribosomes activate angiogenin by rearranging its catalytic center and acting as a specificity factor for tRNA cleavage.
- Angiogenin activation is linked to ribosomes with vacant A sites, which increase during cellular stress.
- Findings may aid in developing therapeutics for cancer and neurodegenerative diseases.
Related Concept Videos
Mechanism of Angiogenesis
tRNA Activation
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Ribosomes
Ribosome Structure and Assembly
Ribosomes are composed of ribosomal RNA (rRNA) and proteins. In eukaryotes, rRNA is transcribed from genes in the nucleolus—a part of the nucleus that specializes in ribosome...
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Regulation of Angiogenesis and Blood Supply

